Academic Journal

Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: A randomized, controlled, proof-of-activity trial

التفاصيل البيبلوغرافية
العنوان: Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: A randomized, controlled, proof-of-activity trial
المؤلفون: Braithwaite, Irene E., Cai, Fang, Tom, Jennifer A., Galanter, Joshua M., Owen, Ryan P., Zhu, Rui, Williams, Mathew, McGregor, Anna G., Eliahu, Avi, Durk, Matthew R., Dengler, Hart S., Zak, Mark, Kenny, Jane R., Wilson, Maria E., Beasley, Richard, Chen, Hubert
المساهمون: Genentech Inc
المصدر: Journal of Allergy and Clinical Immunology ; volume 148, issue 3, page 783-789 ; ISSN 0091-6749
بيانات النشر: Elsevier BV
سنة النشر: 2021
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.jaci.2021.02.042
الاتاحة: http://dx.doi.org/10.1016/j.jaci.2021.02.042
https://api.elsevier.com/content/article/PII:S009167492100422X?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S009167492100422X?httpAccept=text/plain
Rights: https://www.elsevier.com/tdm/userlicense/1.0/ ; http://creativecommons.org/licenses/by-nc-nd/4.0/
رقم الانضمام: edsbas.A7DDE442
قاعدة البيانات: BASE
الوصف
DOI:10.1016/j.jaci.2021.02.042